Investigating new genetic susceptibility loci in osteoarthritis
dc.contributor.advisor
Ralston, Stuart
en
dc.contributor.advisor
Salter, Donald
en
dc.contributor.author
Roberts, Simon Benedict
en
dc.contributor.sponsor
Wellcome Trust
en
dc.date.accessioned
2018-03-26T11:13:07Z
dc.date.available
2018-03-26T11:13:07Z
dc.date.issued
2018-06-30
dc.description.abstract
Primary osteoarthritis (OA) is a late-onset, degenerative condition of synovial joints,
and is the major cause of pain and disability in older persons. OA represents a
significant disease burden and focus of research, especially as no disease-modifying
therapies exist to manage the condition. The genetic influence to OA is complex and
polygenic. The arcOGEN study, the most powerful genome-wide association study yet
to investigate OA in humans, identified the 9q33.1 locus to be significantly associated
with hip OA in females. TRIM32 lies within the 9q33.1 susceptibility locus and may
have strong biological relevance to OA; it encodes a protein with E3 ubiquitin ligase
activity.
Sanger sequencing of TRIM32 in the youngest 500 female patients with hip OA
from the arcOGEN study was performed to identify rare variants in TRIM32 that are
associated with OA of the hip in females. Polymorphisms were identified in the
proximal promoter, and 3’untranslated regions (3’UTR) of TRIM32 that are
disproportionately represented in female patients with hip OA, compared to the control
population.
In vitro studies identified expression of TRIM32 in human femoral head
cartilage; reduced expression of TRIM32 was also demonstrated in femoral head
primary articular chondrocytes from patients with hip OA compared to control patients.
Trim32 knockout resulted in increased aggrecanolysis in murine femoral head explants.
Murine chondrocytes deficient in Trim32 also exhibited increased expression of markers
of a mature chondrocyte phenotype in response to anabolic cytokine stimulation, and
increased expression of markers of a hypertrophic chondrocyte phenotype upon
catabolic cytokine stimulation. In vivo studies of joint degeneration in Trim32 knockout mice demonstrated
increased cartilage degradation and tibial epiphyseal bone changes after surgically
induced knee joint instability, compared to wild-type mice. Increased cartilage
degradation and medial knee subchondral bone changes were also identified upon
ageing of Trim32 knockout mice.
These results further implicate TRIM32 in the genetic predisposition to OA, and
indicate a role for TRIM32 in the joint degeneration evident in OA. These results
support the further study of TRIM32 in the pathophysiology of OA and development of
novel therapeutic strategies to manage OA.
en
dc.identifier.uri
http://hdl.handle.net/1842/28982
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Roberts SB, Wootton E, De Ferrari L, Albagha O, Salter DM. Epigenetics of osteoarticular diseases: recent developments. Rheumatology International. 2015; 35 (8): 1293-1305. PMID: 25812537.
en
dc.relation.hasversion
Roberts SB, Borjesson A, Sophocleous A, Salter DM, Ralston SH. Role of Trim32 in osteoarthritis: Trim32-deficient mice develop accelerated knee osteoarthritis after destabilisation of the medial meniscus (DMM) surgery and upon ageing. Osteoarthritis and Cartilage 2016; 24 (Suppl 1): S18.
en
dc.subject
osteoarthritis
en
dc.subject
genetics
en
dc.subject
TRIM32
en
dc.title
Investigating new genetic susceptibility loci in osteoarthritis
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- Roberts2018.pdf
- Size:
- 3.16 MB
- Format:
- Adobe Portable Document Format
This item appears in the following Collection(s)

